MSHO's Certified Medical Office Manager Hematology & Oncology Certification Course

MSHO's Certified Medical Office Manager Hematology & Oncology Certification (CMOM) Course

Calling all administrators who wish to become CMOM certified! MSHO is conducting the Certified Medical Office Manager (CMOM) Certification Course in partnership with the Practice Management Institute (PMI). Join us to grow your leadership and problem-solving skills. To learn more or to register, click the link below.
more information

MSHO's Board Review & Re-Certification Course

MSHO's Board Review & Re-Certification Course

Master the Latest in Oncology & Hematology! Designed for Fellows and Practicing Oncologists. Stay ahead in your field with our expertly crafted program, your ultimate resource for board exam prep and a cutting-edge review of today’s best practices in diagnosing and treating blood disorders and cancer. To learn more or to register, click the link below.
more information

MSHO's Great Lakes Cancer Conference

MSHO's Great Lakes Cancer Conference

Join MSHO this October 16–17 at The Highlands in Harbor Springs, Michigan, for an unforgettable experience during peak autumn beauty in Northern Michigan. Surrounded by brilliant foliage and serene landscapes, this two-day conference is tailored for nurses and advanced practice providers, offering a perfect blend of education, networking, and relaxation. To learn more or to register, click the link below.

more information

NCCN Guidelines Updates

NCCN Guidelines Updates

August 5, 2025

NCCN Guidelines Navigator™ Published for Uterine Neoplasms.

more information

Healthcare Bill Tracking

Track Healthcare Legislation Happening in Michigan!

Updated July 29, 2025

Follow legislation that MSHO is actively monitoring that may impact you and your patients. 

more information

Previous Next

Advocacy

MSHO continuously contacts legislators, provides comments to policy makers, and collaborates with payers on issues of concern to those delivering care to cancer patients.

more information

Education

It is important that our members are aware of meetings, webinars, and other educational opportunities specifically designed to address the complexities of cancer care.

more information

Research

MSHO is committed to furthering the advancement of cancer care by supporting the many organizations that provide cancer clinical trials to Michigan’s cancer patients.

more information

MSHO Foundation

The MSHO Foundation is a 501c3 organization which was formed in 2011 to address the growing educational needs of hematology and oncology professionals in Michigan.

more information

Job Board

MSHO offers our members an opportunity to share current job openings or post your resume as a job seeker on our website. Click here to view job openings, posted resumes, or to create a new post.

more information

MSHO's 40th Anniversary KudoboardJoin Us in Celebrating 40 Years of MSHO!

As we mark this milestone anniversary, we invite you to share your memories, messages, and photos on our MSHO 40th Anniversary Kudo Board! Whether it’s a story from past meetings, a special connection you made, or a moment that stands out - your contributions will help honor our journey and shape what’s next.

Add your message today and celebrate with us! https://www.kudoboard.com/boards/36YBWnwd. 

Upcoming Events view all events

 August 2025 
SMTWTFS
     1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17181920212223
24252627282930
31      
Fri
1
2025
August 1 - 16, 2025

Certified Medical Office Manager Hematology & Oncology Certification Course

AUGUST 1, 2, 15, 16

MSHO Office

view event details
Fri
15
2025
August 15, 2025

Fellows Dinner & Business Meeting

CANCELED

view event details
Sat
16
2025
August 16, 2025

Board Review & Re-Certification Course

Somerset Inn, Troy

view event details

Latest News view all news

2026 Hospital Outpatient Payment Proposal Includes Payment Rate and Policy Updates
08/11/2025

2026 Hospital Outpatient Payment Proposal Includes Payment Rate and Policy Updates

FDA Grants Accelerated Approval for Jazz Pharmaceutical's Modeyso™ (dordaviprone) as the First and Only Treatment for Recurrent H3 K27M-mutant Diffuse Midline Glioma
08/06/2025

FDA Grants Accelerated Approval for Jazz Pharmaceutical's Modeyso™ (dordaviprone) as the First and Only Treatment for Recurrent H3 K27M-mutant Diffuse Midline Glioma

CMS Expands Access to Life Saving Gene Therapies Through Innovative State Agreements
07/18/2025

CMS Expands Access to Life Saving Gene Therapies Through Innovative State Agreements

Participating states to test outcomes-based payments for sickle cell disease treatments, improving care while lowering long-term costs

YesRx Welcomes Henry Ford Health to YesRx Network
07/18/2025

YesRx Welcomes Henry Ford Health to YesRx Network

Corporate Sponsors view all sponsors